Incretin-based therapy and risk of cholangiocarcinoma: a nested case–control study in a population of subjects with type 2 diabetes

Background and aims One cohort and several basic science studies have raised suspicion about an association between incretin therapies and cholangiocarcinoma. Our aim was to verify the occurrence of CC in relation to incretin-based medication use versus any antidiabetic treatment in an unselected po...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Acta diabetologica Ročník 57; číslo 4; s. 401 - 408
Hlavní autoři:	Giorda, Carlo B., Picariello, Roberta, Tartaglino, Barbara, Nada, Elisa, Costa, Giuseppe, Gnavi, Roberto
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Milan Springer Milan 01.04.2020 Springer Nature B.V
Témata:	Antidiabetics Cholangiocarcinoma Diabetes Diabetes mellitus (non-insulin dependent) GLP-1 receptor agonists Internal Medicine Medicine Medicine & Public Health Metabolic Diseases Original Article Patients Population Population studies Risk factors Safety in diabetes treatment Administrative data Incretin-based medications Case–control study Cholangiocarcinoma
ISSN:	0940-5429, 1432-5233, 1432-5233
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!